Back to today’s briefing

Story perspectives

Breakthrough Compound Boosts Muscle Strength in DMD Research

7/19/2025

39 5

Summary

Story summary

Researchers at VIB-KU Leuven in Belgium have made a groundbreaking discovery in the fight against Duchenne muscular dystrophy (DMD). By targeting glutamate dehydrogenase 1 (GLUD1) with the compound R162, they found significant improvements in muscle strength and coordination in preclinical models, paving the way for a promising new treatment strategy that goes beyond merely managing symptoms.

1 of 1

Story summary

Researchers at VIB-KU Leuven in Belgium have made a groundbreaking discovery in the fight against Duchenne muscular dystrophy (DMD). By targeting glutamate dehydrogenase 1 (GLUD1) with the compound R162, they found significant improvements in muscle strength and coordination in preclinical models, paving the way for a promising new treatment strategy that goes beyond merely managing symptoms.